Stockreport

Sea Pharmaceuticals Advancing Oral Neurotherapeutics as Potential Medicines for Tinnitus, Epilepsy, and ALS in Collaboration with TCG GreenChem [Yahoo! Finance]

WOLTERS KLUWER S/ADR  (WTKWY) 
NASDAQ:AMEX Investor Relations: wolterskluwer.com/investors
PDF Two potent, selective, pre-clinical stage molecules are being advanced as possible treatments for three therapeutic indications Sea's lead SPM-0404 in investigational [Read more]